周四，H.C. Wainwright维持对Adicet Bio Inc. (NASDAQ: ACET)股票的中性立场，此前该公司宣布美国食品和药物管理局(FDA)同意修改其新药研究申请(IND)。这项修改将允许Adicet Bio在其正在进行的1期试验中评估其药物候选ADI-001对其他自身免疫性疾病的治疗效果。 Adicet Bio的同种异体γδ T细胞产品候选ADI-001包含一个抗CD20 ...

Adicet Bio ( (ACET) ) has provided an update. Adicet Bio has received FDA clearance to expand its investigational new drug ...

加利福尼亚州红木城和马萨诸塞州波士顿 - 临床阶段生物技术公司Adicet Bio, Inc. (NASDAQ: ...

In a report released today, Edward White from H.C. Wainwright reiterated a Hold rating on Adicet Bio (ACET – Research Report). The ...

加拿大投资银行集团：维持Adicet Bio(ACET.US)评级，由买入调整至买入评级, 目标价由19.00美元调整至8.00美元。 艾切托（ACET.US）公司简介：Adicet Bio Inc是 ...

We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free) according to the hedge funds using the latest sentiment data. In this article, we are going to take a look at where ...

On September 30, 2024, Millennium Management LLC, a prominent hedge fund, executed a significant transaction involving the ...

ADI-001 clinical development program now addresses six autoimmune diseases. Patient enrollment for idiopathic inflammatory myopathy and stiff person syndrome cohort expected to be ...

In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Adicet Bio (ACET – Research Report). The company’s shares closed yesterday at $1.52 ...

This used to be such a nice space to study and hang out … it was kind of a common vibe,” said Markel, “and now we don't have ...